|Report ID : RNR-199994||Category : Medical Devices||Published Date : Dec-17|
|Publisher : Research-N-Reports||Pages : 123||Format : PDF|
Research N Reports added new report titled “Diabetes Care Devices & Drugs Market by Type of Devices (Continuous Blood Glucose Monitoring Devices, Test Strips, Lancets, Self-monitoring Devices, Hemoglobin A1c Testing Kits, Insulin Syringes, Insulin Pens, Insulin Pumps, Insulin Jet Injectors); by Type of Drugs (Insulin, Oral Hypoglycemic Agents, and Non-Insulin Injectable); by Regions (North America, Europe, Asia-Pacific (APAC), Middle East & Africa and Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2017-2025.” Diabetes is one of the largest global health emergencies of the 21st century. Each year more and more people live with this condition, which can result in life-changing complications. The incidence & prevalence of diabetes is growing with rising obesity rates, changing lifestyle and dietary habits, and growing ageing population. Therefore, given the huge numbers of diabetics worldwide and the huge financial implications associated with diabetes and related further health complications, there is a substantial market potential in the global market over the forecast period. In terms of revenue, the Global Diabetes Care Devices & Drugs Market was valued at US$ xxxx Mn in 2016 and is expected to reach US$ xxxx Mn by 2025, expanding at a CAGR of xx% from 2017 to 2025. The Global Diabetes Care Devices & Drugs Market is enhanced by factors such as: • Increasing prevalence of diabetes care patients. • Rising minimum/non-invasive products. • Growing awareness of diabetes care devices. • Development need for faster, safer and effective method of diagnosis and treatment of diabetes. Based on type of devices, the continuous blood glucose monitoring devices segment is estimated to experience rapid growth due to rise in the prevalence of diabetes, increase in geriatric population, high demand of self-care, and technological advancements in blood glucose monitoring devices. In addition, increase in online marketing strategies by key vendors fosters the growth of the segment during the research period. On the basis of type of drugs, the global market is segmented into insulin, oral hypoglycemic agents, and non-insulin injectable. Out of these, the insulin segment alleged the largest share of the global market in the past years and it is further expected to dominate the market in the forthcoming years. The largest share of the segment is mainly attributed to the increasing use of insulin to control the glucose levels in blood for type 1 diabetes patients, rising market demand for human insulin analogs, and favorable medical reimbursements. In terms of geography, North America registered for the foremost share of the Global Diabetes Care Devices & Drugs Market in 2016, followed by Europe, and Asia Pacific. The major share of the region is mainly attributed to the large & growing base of diabetic patients, well-established healthcare infrastructure, and higher adoption of technologically innovative diabetic care products. However, Asia Pacific is projected to grow at the fastest CAGR over the conjecture period. The growth is due to increasing greying population, rising burden of diabetic population, various government initiatives to increase the awareness & prevention of diseases, and increasing sedentary lifestyles in developing countries such as India & China. Some of the significant players functioning in the Global Diabetes Care Devices & Drugs Market include Novo Nordisk A/S, Ypsomed AG, Abbott, Ascensia Diabetes Care Holdings AG, Eli Lilly and Company, Hoffmann-La Roche Ltd., Johnson & Johnson, Medtronic PLC, Becton, Dickinson and Company, Terumo Corporation, Sanofi S.A., Merck & Co., Inc.,Novartis AG, AstraZeneca PLC, Boehringer Ingelheim GmbH, and so on.
Table of Contents Chapter One Global Diabetes Care Devices & Drugs Market Overview 1.1 Definition (Product Picture and Specifications) 1.2 Classification and Application 1.3 Global Market Chain Structure 1.4 Industry Overview 1.5 Industry History 1.6 Industry Competitive Landscape 1.7 Industry Global Development Comparison Chapter Two Diabetes Care Devices & Drugs Market Data Analysis 2.1 2017 Global Key Manufacturers, Price List 2.2 2017 Global Key Manufacturers -Gross Margin List 2.3 Key Manufacturers, Market Capacity and Share List 2.4 2017 Global Key Manufacturers, Production and Market Share List 2.5 2017 Global Key Manufacturers, Production Value and Market Share List Chapter Three Diabetes Care Devices & Drugs Technical Data Analysis 3.1 2017 Global Key Manufacturers, Product Quality List 3.2 2017 Global Key Manufacturers, Product Line Capacity and Commercial Production Date 3.3 2017 Manufacturing Base (Factory) List, Market Regional Distribution 3.4 2017 Global Key Manufacturers Market R&D Status and Technology Sources 3.5 2017 Global Key Manufacturers Equipment Investment and Performance 3.6 2017 Global Key Manufacturers Raw Materials Sources Analysis Chapter Four DIABETES CARE DEVICES & DRUGS Government Policy and News 4.1 Government Related Policy Analysis 4.2 Industry News Analysis 4.3 Industry Development Trend Chapter Five Global Diabetes Care Devices & Drugs Market Manufacturing Process and Cost Structure 5.1 Product Specifications 5.2 Manufacturing Process Analysis 5.3 Cost Structure Analysis Chapter Six 2012-2017 Diabetes Care Devices & Drugs Productions Supply Sales Demand Market Status and Forecast 6.1 2012-2017 Global Market Capacity Production Overview 6.2 2012-2017 Global Market Capacity Utilization Rate 6.3 2012-2017 Key Manufacturers Diabetes Care Devices & Drugs Price Gross Margin List 6.4 2012-2017 Global Key Manufacturers Diabetes Care Devices & Drugs Production Value Overview 6.5 2012-2017 Global Production Market Share by Product Type 6.6 2012-2017 Market Consumption Share by Application 6.7 2012-2017 Global Diabetes Care Devices & Drugs Production Market Share by US EU China Japan etc Regions 6.8 2012-2017 Market Demand Overview 6.9 2012-2017 Market Supply Demand and Shortage 6.10 2012-2017 Global Cost Price Production Value Gross Margin Chapter Seven Diabetes Care Devices & Drugs Key Manufacturers 7.1 Company Analysis 7.1.1 Company Profile 7.1.2 Product Picture and Specification 7.1.3 Capacity Production Price Cost Production Value 7.1.4 Contact Information 7.2 Company B 7.2.1 Company Profile 7.2.2 Product Picture and Specification 7.2.3 Capacity Production Price Cost Production Value 7.2.4 Contact Information 7.3 Company C 7.3.1 Company Profile 7.3.2 Product Picture and Specification 7.3.3 Capacity Production Price Cost Production Value 7.3.4 Contact Information 7.4 Company D 7.4.1 Company Profile 7.4.2 Product Picture and Specification 7.4.3 Capacity Production Price Cost Production Value 7.4.4 Contact Information 7.5 Company E 7.5.1 Company Profile 7.5.2 Product Picture and Specification 7.5.3 Capacity Production Price Cost Production Value 7.5.4 Contact Information Chapter Eight Up and Down Stream Industry Analysis 8.1 2012-2017 Global Diabetes Care Devices & Drugs Market: Key Raw Materials Price Analysis 8.2 2016 Key Product Line Investments Analysis 8.3 2017-2025 Downstream Applications Demand Analysis Chapter Nine: Marketing Strategy -Diabetes Care Devices & Drugs y Analysis 9.1 Marketing Channels Analysis 9.2 New Project Marketing Strategy Proposal Chapter Ten 2017-2025 Diabetes Care Devices & Drugs Development Trend Analysis 10.1 2017-2025 Market Production Development Trend 10.2 2017-2025 Market Demand Forecast Chapter Eleven Global Diabetes Care Devices & Drugs Market New Project Investment Feasibility Analysis 11.1 Project SWOT Analysis 11.2 Diabetes Care Devices & Drugs New Project Investment Feasibility Analysis